Ralph Brandenberger
Direttore Tecnico/Scientifico/R&S presso NKARTA, INC.
Patrimonio netto: 545 409 $ in data 30/04/2024
Posizioni attive di Ralph Brandenberger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NKARTA, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 | - |
| Corporate Officer/Principal | 01/04/2018 | 01/01/2020 |
Storia della carriera di Ralph Brandenberger
Precedenti posizioni note di Ralph Brandenberger
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/05/2016 | 01/03/2018 |
Baxalta US, Inc.
 Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Corporate Officer/Principal | 01/11/2012 | 01/04/2016 |
| GERON CORPORATION | Corporate Officer/Principal | 01/08/2001 | 01/06/2012 |
Formazione di Ralph Brandenberger
| University of Basel | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Svizzera | 2 |
Posizioni
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| NKARTA, INC. | Health Technology |
| GERON CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Neurona Therapeutics, Inc.
Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Health Technology |
Baxalta US, Inc.
Baxalta US, Inc. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Baxalta US, Inc. engages in the research, development, and manufacture of biopharmaceutical products. The company is based in Deerfield, IL. | Health Technology |
- Borsa valori
- Insiders
- Ralph Brandenberger
- Esperienza
